Glycine Accelerates Recovery from Alcohol-Induced Liver Injury1

  1. Ming Yin,
  2. Kenichi Ikejima,
  3. Gavin E. Arteel,
  4. Vitor Seabra,
  5. Blair U. Bradford,
  6. Hiroshi Kono,
  7. Ivan Rusyn and
  8. Ronald G. Thurman
  1. Laboratory of Hepatobiology and Toxicology, Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

    Abstract

    Glycine prevents hepatic damage caused by hypoxia-reoxygenation, diminishes mortality due to endotoxin and minimizes alcoholic liver injury by decreasing blood ethanol. Our purpose was to investigate the effect of dietary glycine during recovery from early alcohol-induced injury, using a model that mimics the clinical presentation and histopathology with alcoholics. Male Wistar rats were exposed to ethanol continuously for 6 wk via intragastric feeding that resulted in typical histology of alcoholic liver injury, including steatosis, inflammation, necrosis and increased serum levels of aspartate aminotransferase and alanine aminotransferase. After cessation of ethanol, one group of rats received a control diet, the other a glycine-containing diet for 2 wk. During this period, all parameters studied tended to return to baseline values. However, serum aspartate aminotransferase and alanine aminotransferase recovered about 30% more rapidly in rats fed glycine. Further, the hepatic pathology score was also significantly lower in the glycine group than in controls (0.5vs. 2.6). After 1 wk, steatosis was reduced significantly more in the glycine group (5.6%) than in controls (8.9%). Glycine also diminished numbers of infiltrating leukocytes and necrotic cells significantly more than in controls. This beneficial effect of glycine may be partly explained by the fact that glycine increased influx of chloride into Kupffer cells leading to diminished tumor necrosis factor-α production. These results indicate that a glycine containing diet expedites the process of recovery from ethanol-induced liver injury and may lead to its clinical application in alcoholic hepatitis.

    Footnotes

    • Send reprint requests to: Dr. Ronald G. Thurman, Department of Pharmacology, Laboratory of Hepatobiology and Toxicology, CB# 7365, Faculty Laboratory Office Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365.

    • 1 This work was supported in part by Grant AA-03624 from the National Institutes of Health.

    • Abbreviations:
      ALD
      alcoholic liver disease
      AST
      aspartate aminotransferase
      ALT
      alanine aminotransferase
      GdCl3
      gadolinium chloride
      LPS
      lipopolysaccharide
      NAD+
      nicotinamide adenine dinucleotide
      TNFα
      tumor necrosis factor-α
      RT-PCR
      reverse transcriptase polymerase chain reaction
      [Ca++]i
      intracellular Ca++
      HEPES
      N-[2-Hydroxyethyl]piperazine-N′-[2-ethanesulfonic acid
      • Received January 23, 1998.
      • Accepted April 15, 1998.
    « Previous | Next Article »Table of Contents